Deep Lens Closes $14 Million Series A Financing to Further Advance Digital AI Pathology Platform for Clinical Trial Recruitment COLUMBUS, Ohio, April 8, 2019-- Deep Lens, Inc., an AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis, announced today the company has closed a $14 million Series A financing, led by Northpond Ventures. Existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners also participated in this round, which comes just three months after Deep Lens closed its VC-led seed equity round. Funding to date now totals $17.5 million.